Activation of natural killer cells inhibits liver fibrosis: a novel strategy to treat liver fibrosis (Q37346066)

19 August 2017

1 reference

title

Activation of natural killer cells inhibits liver fibrosis: a novel strategy to treat liver fibrosis (English)

1 reference

19 August 2017

Bin Gao

1

1 reference

19 August 2017

Svetlana Radaeva

series ordinal

2

1 reference

19 August 2017

Won-Il Jeong

series ordinal

3

1 reference

19 August 2017

publication date

1 October 2007

1 reference

Expert Review of Gastroenterology & Hepatology

19 August 2017

published in

1 reference

19 August 2017

volume

1

1 reference

19 August 2017

issue

1

1 reference

19 August 2017

page(s)

173-180

1 reference

Hepatic fibrosis 2006: report of the Third AASLD Single Topic Conference.

19 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1586%2F17474124.1.1.173

Models of liver fibrosis: exploring the dynamic nature of inflammation and repair in a solid organ

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F17474124.1.1.173

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F17474124.1.1.173

Liver fibrosis: from the bench to clinical targets

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F17474124.1.1.173

Mechanisms of liver fibrosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F17474124.1.1.173

Transforming growth factor beta and the liver

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F17474124.1.1.173

Suppression of macrophage infiltration inhibits activation of hepatic stellate cells and liver fibrogenesis in rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F17474124.1.1.173

Stimulation of hepatic lipocyte collagen production by Kupffer cell-derived transforming growth factor beta: implication for a pathogenetic role in alcoholic liver fibrogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F17474124.1.1.173

Attenuated liver fibrosis in the absence of B cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F17474124.1.1.173

Strain-specific differences in mouse hepatic wound healing are mediated by divergent T helper cytokine responses

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F17474124.1.1.173

Infiltrating neutrophils in bile duct-ligated livers do not promote hepatic fibrosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F17474124.1.1.173

Natural killer cells ameliorate liver fibrosis by killing activated stellate cells in NKG2D-dependent and tumor necrosis factor-related apoptosis-inducing ligand-dependent manners

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F17474124.1.1.173

Anti-fibrotic activity of NK cells in experimental liver injury through killing of activated HSC.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F17474124.1.1.173

Natural killer cells and their receptors

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F17474124.1.1.173

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F17474124.1.1.173

Mouse Ly49 NK receptors: balancing activation and inhibition

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F17474124.1.1.173

Natural killer cell signaling pathways

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F17474124.1.1.173

Retinoic acid early inducible genes define a ligand family for the activating NKG2D receptor in mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F17474124.1.1.173

Activation of NK cells and T cells by NKG2D, a receptor for stress-inducible MICA

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F17474124.1.1.173

ULBPs, novel MHC class I-related molecules, bind to CMV glycoprotein UL16 and stimulate NK cytotoxicity through the NKG2D receptor

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F17474124.1.1.173

ULBP4 is a novel ligand for human NKG2D

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F17474124.1.1.173

IFN-gamma, produced by NK cells that infiltrate liver allografts early after transplantation, links the innate and adaptive immune responses

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F17474124.1.1.173

IL-6 prevents T cell-mediated hepatitis via inhibition of NKT cells in CD4+ T cell- and STAT3-dependent manners

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F17474124.1.1.173

Gene therapy of orthotopic hepatocellular carcinoma in rats using adenovirus coding for interleukin 12.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F17474124.1.1.173

Natural killer activity of human liver-derived lymphocytes in various liver diseases

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F17474124.1.1.173

NK cells in innate immunity

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F17474124.1.1.173

Activation and function of hepatic NK cells in hepatitis B infection: an underinvestigated innate immune response

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F17474124.1.1.173

Natural killer cells inhibit hepatitis C virus expression

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F17474124.1.1.173

HLA and NK cell inhibitory receptor genes in resolving hepatitis C virus infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F17474124.1.1.173

Natural killer cells: primary target for hepatitis C virus immune evasion strategies?

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F17474124.1.1.173

Role of NK and NKT cells in the immunopathogenesis of HCV-induced hepatitis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F17474124.1.1.173

Involvement of natural killer cells in PolyI:C-induced liver injury

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F17474124.1.1.173

Liver NK cells expressing TRAIL are toxic against self hepatocytes in mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F17474124.1.1.173

Negative regulation of liver regeneration by innate immunity (natural killer cells/interferon-gamma).

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F17474124.1.1.173

STAT1 contributes to dsRNA inhibition of liver regeneration after partial hepatectomy in mice.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F17474124.1.1.173

STAT1 inhibits liver fibrosis in mice by inhibiting stellate cell proliferation and stimulating NK cell cytotoxicity.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F17474124.1.1.173

Inhibition of transforming growth factor-beta/SMAD signalling by the interferon-gamma/STAT pathway.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F17474124.1.1.173

Activated stellate cells express the TRAIL receptor-2/death receptor-5 and undergo TRAIL-mediated apoptosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F17474124.1.1.173

NK cells cause liver injury and facilitate the induction of T cell-mediated immunity to a viral liver infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F17474124.1.1.173

Natural killer T (NKT) cells attenuate bleomycin-induced pulmonary fibrosis by producing interferon-gamma

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F17474124.1.1.173

Decrease in CD3-negative-CD8dim(+) and Vdelta2/Vgamma9 TcR+ peripheral blood lymphocyte counts, low perforin expression and the impairment of natural killer cell activity is associated with chronic hepatitis C virus infection.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F17474124.1.1.173

Long-term administration of interferon-alpha in non-responder patients with chronic hepatitis C: follow-up of liver fibrosis over 5 years

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F17474124.1.1.173

Interferon alfa down-regulates collagen gene transcription and suppresses experimental hepatic fibrosis in mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F17474124.1.1.173

Inhibition of rat hepatic lipocyte activation in culture by interferon-gamma

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F17474124.1.1.173

Effect of interferon-gamma on hepatic fibrosis in chronic hepatitis B virus infection: a randomized controlled study

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F17474124.1.1.173

Interferon gamma-1b for the treatment of fibrosis in chronic hepatitis C infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F17474124.1.1.173

Final results of a double-blind, placebo-controlled trial of the antifibrotic efficacy of interferon-gamma1b in chronic hepatitis C patients with advanced fibrosis or cirrhosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F17474124.1.1.173

Resolving fibrosis in the diseased liver: translating the scientific promise to the clinic.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F17474124.1.1.173

Natural killer cell receptors specific for major histocompatibility complex class I molecules

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F17474124.1.1.173

Receptors for HLA class-I molecules in human natural killer cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F17474124.1.1.173

HLA-E binds to natural killer cell receptors CD94/NKG2A, B and C

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F17474124.1.1.173

Mouse CD94/NKG2A is a natural killer cell receptor for the nonclassical major histocompatibility complex (MHC) class I molecule Qa-1(b)

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F17474124.1.1.173

Human natural killer cell receptors and co-receptors

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F17474124.1.1.173

Recognition of haemagglutinins on virus-infected cells by NKp46 activates lysis by human NK cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F17474124.1.1.173

Recognition of viral hemagglutinins by NKp44 but not by NKp30.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F17474124.1.1.173

The mechanisms controlling the recognition of tumor- and virus-infected cells by NKp46

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F17474124.1.1.173

Characterization of the heparin/heparan sulfate binding site of the natural cytotoxicity receptor NKp46

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F17474124.1.1.173

HLA-E is a major ligand for the natural killer inhibitory receptor CD94/NKG2A

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F17474124.1.1.173

Recognition of the class Ib molecule Qa-1(b) by putative activating receptors CD94/NKG2C and CD94/NKG2E on mouse natural killer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F17474124.1.1.173

Inhibition of the NKp30 activating receptor by pp65 of human cytomegalovirus

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F17474124.1.1.173

21 January 2018

Identifiers

DOI

10.1586/17474124.1.1.173

1 reference

19 August 2017

1 reference